Partial thromboplastin time (PTT)?

1 Answer

Answer :

DefinitionPartial thromboplastin time (PTT) is a blood test that looks at how long it takes for blood to clot. It can help tell if you have bleeding or clotting problems.Alternative NamesAPTT; PTT; Activated partial thromboplastin timeHow the test is performedThe health care provider uses a needle to take blood from one of your veins. The blood collects into an air-tight container. You may be given a bandage to stop any bleeding. If you are taking a medicine called heparin, you will be watched for signs of bleeding.The laboratory specialist will add chemicals to the blood sample and see how many seconds it takes for the blood to clot.How to prepare for the testThe health care provider may tell you to stop taking certain drugs before the test. Drugs that can affect the results of a PTT test

Related questions

Description : The patient whom you are about to treat states that he has Von Willebrand's disease. Which one of the following preoperative haematological analyses may reflect this disease: A. Bleeding time and ... C. Bleeding time and factor X level D. Platelet count E. Thromboplastin generation time

Last Answer : A. Bleeding time and factor VIII level ptt also prolonged decreased platelet count

Description : Tests of coagulation are used to monitor anticoagulation treatment and detect intrinsic abnormalities in coagulation. Which of the following statement(s) is/are true concerning ... is used to monitor heparin levels intraoperatively during cardiovascular and peripheral vascular operations

Last Answer : Answer: a, c, d Coagulation tests include prothrombin time (PT), which measures the intrinsic and extrinsic pathways of fibrinogen production and is the most common method for ... more while for peripheral vascular applications, values of 250 seconds or greater are considered appropriate

Description : Mini-dose heparin has been shown to be useful in the prophylaxis of postoperative venous thrombosis. Mechanism(s) by which low-dose heparin is/are thought to protect against venous ... aggregation and subsequent platelet release action d. A mild prolongation of activated partial thromboplastin time

Last Answer : Answer: a, b, c Low-dose heparin is thought to protect against venous thrombosis through three different mechanisms. First, antithrombin III activity with its inhibition of activated Factor X is ... release reaction. The standard doses of heparin administered (5000 units bid) does not affect aPTT

Description : Which of the following statement(s) concerning laboratory studies used in monitoring a patient with intravenous heparinization is/are correct? a. The platelet count should be followed because of the ... serum creatinine should be measured daily to allow adjustments in dose based on renal function

Last Answer : Answer: a, c In monitoring the effect of heparin, an activated partial thromboplastin time (aPTT) of 1.5 control or a thrombin clotting time (TCT) of 2 times control reflects adequate ... system. Therefore the dose of heparin need not be adjusted in cases of liver or renal dysfunction

Description : The evaluation of a patient scheduled for elective surgery should always include the following as tests of hemostasis and coagulation: A. History and physical examination. B. Complete blood count ( ... (APTT). D. Studies of platelet aggregation with adenosine diphosphate (ADP) and epinephrine.

Last Answer : Answer: A DISCUSSION: The evaluation of most patients scheduled for elective surgery who do not have a history of significant bleeding disorders is somewhat controversial. An adequate history and ... suspected of having qualitative defects of platelet function (e.g., von Willebrand's disease)

Description : The transfusion of fresh frozen plasma (FFP) is indicated for which of the following reasons? A. Volume replacement. B. As a nutritional supplement. C. Specific coagulation factor deficiency ... the correction of abnormal PT secondary to warfarin therapy, vitamin K deficiency, or liver disease.

Last Answer : Answer: CD DISCUSSION: The use of FFP as a volume expander is not indicated. There are currently several preparations (both crystalloid and colloid) that are equally effective and do not carry the infectious and ... vitamin K-dependent factors II, VII, IX, and X, as well as protein C and protein S

Description : Low doses of heparin prolong: A. Bleeding time B. Activated partial thromboplastin time C. Prothrombin time D. Both ‘B’ and ‘C’

Last Answer : B. Activated partial thromboplastin time

Description : Von Willebrand disease is, A. Haemophilic disease B. Bacterial Endocarditis C. Congenital cardiac disease D. Rheumatic fever Decreased PTT, bleeding time prolonged, deficiency factor VIII

Last Answer : A. Haemophilic disease

Description : File extension for a PowerPoint 2007 presentation is ………………. (a) .ptt (b) .pptx (c) .docx (d) .clsx -Technology

Last Answer : (b) .pptx is the file extension given to all PowerPoint 2007 files.

Description : Thromboplastin is secreated by `:-`

Last Answer : Thromboplastin is secreated by `:-` A. Kidney B. Platelets C. Leucocyte D. Erythrocyte

Description : Vitamin K is required for (a) change of prothrombin into thrombin (b) synthesis of prothrombin (c) change of fibrinogen to fibrin (d) formation of thromboplastin.

Last Answer : (b) synthesis of prothrombin

Description : Platelets play an important role in haemostasis; which of the following describes this role? A. They convert fibrinogen to fibrin B. They agglutinate and plug small, ruptured ... thrombosis D. They supply fibrin stabilizing factors E. They supply proconvertin for thromboplastin activation

Last Answer : B. They agglutinate and plug small, ruptured vessels